Distinct gene expression patterns of peripheral blood cells in hyper–IgE syndrome

Hyper‐immunoglobulin E (IgE) syndrome (HIES) is one of the primary immunodeficiency syndromes. Although the cytokine dysregulation is suggested to play a role in its pathophysiology, the causative gene has not yet been identified. To investigate the pathophysiology and candidate genes involved in this disease, we performed microarray analysis of unstimulated peripheral CD4+ T cells and CD14+ cells, as well as peripheral blood mononuclear cells (PBMNC) stimulated with Staphylococcus aureus isolated from HIES patients and healthy controls. By microarray analysis, 38 genes showed over 2‐fold differences between the HIES patients and healthy controls in purified CD14+ cells, although only small differences in the gene expression profiles were observed between the two groups in purified CD4+ T cells. RGC32 expression levels showed the greatest difference between the two groups, and were significantly  elevated  in  HIES  compared  with  those  in  severe  atopic  dermatitis or healthy controls using real‐time PCR. A significantly larger number of lysosome‐related genes were up‐regulated, and significantly larger number of genes related to cell growth and maintenance were down‐regulated in HIES. After the stimulation of PBMNC with Staphylococcus aureus, 51 genes showed over 3‐fold differences between HIES patients and healthy controls. A significantly large number of immunoglobulin‐related genes were up‐regulated in HIES. The distinct patterns of gene expression profiles and RGC32 expression levels will be useful for understanding the pathophysiology and for diagnosis of HIES, respectively.

[1]  G. Lisignoli,et al.  Human osteoblasts express functional CXC chemokine receptors 3 and 5: Activation by their ligands, CXCL10 and CXCL13, significantly induces alkaline phosphatase and β‐N‐acetylhexosaminidase release , 2003, Journal of cellular physiology.

[2]  D. Goldblatt,et al.  Increased expression of interleukin‐13 but not interleukin‐4 in CD4+ cells from patients with the hyper‐IgE syndrome , 2002, Clinical and experimental immunology.

[3]  J. Shellito,et al.  Requirement of Interleukin 17 Receptor Signaling for Lung Cxc Chemokine and Granulocyte Colony-Stimulating Factor Expression, Neutrophil Recruitment, and Host Defense , 2001, The Journal of experimental medicine.

[4]  K. Sullivan,et al.  Cytokine and chemokine dysregulation in hyper-IgE syndrome. , 2001, Clinical immunology.

[5]  H. Hill,et al.  Defective interleukin-12/interferon-gamma pathway in patients with hyperimmunoglobulinemia E syndrome. , 2000, The Journal of pediatrics.

[6]  A. Schäffer,et al.  Genetic linkage of hyper-IgE syndrome to chromosome 4. , 1999, American journal of human genetics.

[7]  T. Martin,et al.  IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. , 1999, The Journal of clinical investigation.

[8]  S. Holland,et al.  Hyper-IgE syndrome with recurrent infections--an autosomal dominant multisystem disorder. , 1999, The New England journal of medicine.

[9]  J. Lötvall,et al.  Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. , 1999, Journal of immunology.

[10]  C. Montoya,et al.  Interleukin 4 and interferon-gamma secretion by antigen and mitogen-stimulated mononuclear cells in the hyper-IgE syndrome: no TH-2 cytokine pattern. , 1998, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[11]  T. Badea,et al.  Molecular Cloning and Characterization of RGC-32, a Novel Gene Induced by Complement Activation in Oligodendrocytes* , 1998, The Journal of Biological Chemistry.

[12]  R. de Waal Malefyt,et al.  Interleukin-17 and interferon-gamma synergize in the enhancement of proinflammatory cytokine production by human keratinocytes. , 1998, The Journal of investigative dermatology.

[13]  James G. Boyd,et al.  Interferon–inducible T Cell Alpha Chemoattractant (I-TAC): A Novel Non-ELR CXC Chemokine with Potent Activity on Activated T Cells through Selective High Affinity Binding to CXCR3 , 1998, The Journal of experimental medicine.

[14]  Yulan He,et al.  IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages. , 1998, Journal of immunology.

[15]  J. Banchereau,et al.  T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines , 1996, The Journal of experimental medicine.

[16]  Z. Ikezawa,et al.  [Hyper IgE syndrome--a disease of imbalanced activation of helper T-cell subsets?]. , 1990, Arerugi = [Allergy].

[17]  R. Geha,et al.  Regulation of immunoglobulin (Ig)E synthesis in the hyper-IgE syndrome. , 1990, The Journal of clinical investigation.

[18]  M. de Carli,et al.  Defective in vitro production of gamma-interferon and tumor necrosis factor-alpha by circulating T cells from patients with the hyper-immunoglobulin E syndrome. , 1989, The Journal of clinical investigation.

[19]  S. Dreskin,et al.  Evolution of the hyperimmunoglobulin E and recurrent infection (HIE, JOB's) syndrome in a young girl. , 1987, The Journal of allergy and clinical immunology.

[20]  H. Ochs,et al.  Defect in neutrophil granulocyte chemotaxis in Job's syndrome of recurrent "cold" staphylococcal abscesses. , 1974, Lancet.

[21]  J. Schaller,et al.  Job's Syndrome. Recurrent, "cold", staphylococcal abscesses. , 1966 .

[22]  J. Lötvall,et al.  Increased elastase and myeloperoxidase activity associated with neutrophil recruitment by IL-17 in airways in vivo. , 2000, The Journal of allergy and clinical immunology.

[23]  R. Buckley,et al.  Extreme hyperimmunoglobulinemia E and undue susceptibility to infection. , 1972, Pediatrics.